Great Point Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$50.4K	–	34
2024 Q2	$50.4K	Buy	+30,000	New	+$50.4K	0.01%	33